Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia (Q29615030)
scientific article (publication date: August 2002)
Language:
(P31) (Q13442814)
(P304) 117-25
(P407) (Q1860)
(P433) 2
(P478) 2
(P577) +2002-08-00T00:00:00Z
(P921) (Q729735)
(Q29496)
(Q177094)
(P1433) (Q280018)
(P1476) "Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia" (language: en)
(P2093) Shah NP
Nicoll JM
Nagar B
Gorre ME
Paquette RL
Kuriyan J
Sawyers CL
(P2860) (Q38354181)
(Q43744914)
(Q43966244)
(Q33682660)
(Q41743756)
(Q33336718)
(Q29547900)
(Q33919315)
(Q27860751)
(Q73088370)
(Q29618788)
(Q43893091)
(Q29616450)
(Q43847759)
(Q43899710)
(Q33764518)
(Q28590355)
(Q50510027)
(Q33603077)
(Q43977683)
(Q27627097)
(Q28239339)
(Q43904522)
(Q45712588)
(Q27734052)
(Q24295019)
other details
description scientific article (publication date: August 2002)

External Links